Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMDL Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Alan S who wrote (22)	4/2/1998 8:56:00 AM
From: Stock Puppy	Respond to of 28

Two threads on this topic: This one here and in medical devices: AMDL Inc (OTC BB:AMDD) 18 month target $10 Subject 6085 there has been a flurry of discussion. (I think the thread started well over 18 months ago :-)) I hope that this thread can discuss more serious aspects of AMDL (Tho like most, I don't have much info) Since you've posted to the other group, you know that some penny stock newletter recommended this thing, so the price rise is probably more a reflection of that and the day traders than the news release: "AMDL Cancer Screening Test Kit Determined Useful, Reliable in Detecting Cancer; Clinical Trials in China" biz.yahoo.com I think that the statement in the release : "AMDL is in the process of submitting the results of the clinical trial to the Chinese Ministry of Health for approval to market its kit in the world's most populous nation. " is key - until AMDL AMDL is able to do wholesale marketing of their product, stock price is just speculation (playing which is where you can lose or win big :-)). I believe that aceppted for clinical trials in China doesn't mean much for USA market - there would still have to be clinical trials in the US and FDA aproval before marketing is allowed. So, I guess the next questions are: How long do clinical trials take? (in general...) and for the China market, is there the equivalent of FDA approval in China?